NAMI
BMRN icon

Nomura Asset Management International’s BioMarin Pharmaceuticals BMRN Stock Holding History

Nomura Asset Management International’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.71M Buy
169,746
+6,134
+4% +$336K 0.01% 758
2026
Q1 		$9.24M Buy
163,612
+41,912
+34% +$2.44M 0.02% 696
2025
Q4 		$7.23M Buy
+121,700
New +$6.63M 0.01% 748

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Nomura Asset Management International's BMRN Position: Q2 2026 in Review

Nomura Asset Management International increased its BioMarin Pharmaceuticals (BMRN) stake by 3.7% in Q2 2026, buying an estimated $336K and bringing the position to 169,746 shares worth $9.71M. The position accounts for 0.01% of the portfolio, ranked #758.

Nomura Asset Management International first reported a position in BMRN in Q4 2025 and has held it in 3 quarters since. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Nomura Asset Management International held 169,746 shares of BioMarin Pharmaceuticals worth $9.71M as of Q2 2026.
  • Nomura Asset Management International bought 6,134 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $336K.
  • BioMarin Pharmaceuticals made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #758 holding.
  • Nomura Asset Management International first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.